Scarica l'app Stockscreener
1.54
0.65%
-0.01
Dopo l'orario di chiusura:
1.53
-0.01
-0.65%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché ADIL Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.55
Aprire:
$1.55
Volume 24 ore:
86,508
Relative Volume:
0.84
Capitalizzazione di mercato:
$2.20M
Reddito:
-
Utile/perdita netta:
$-7.98M
Rapporto P/E:
-0.1756
EPS:
-8.7693
Flusso di cassa netto:
$-6.49M
1 W Prestazione:
-1.28%
1M Prestazione:
-9.94%
6M Prestazione:
-82.73%
1 anno Prestazione:
-91.07%
Intervallo 1D:
$1.51
$1.5793
Intervallo di 1 settimana:
$1.51
$1.61
Portata 52W:
$1.51
$30.25
Adial Pharmaceuticals Inc Stock (ADIL) Company Profile
Nome
Adial Pharmaceuticals Inc
Settore
Industria
Telefono
434-422-9800
Indirizzo
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Compare ADIL vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADIL
Adial Pharmaceuticals Inc
|
1.54 | 2.23M | 0 | -7.98M | -6.49M | -8.7693 |
VRTX
Vertex Pharmaceuticals Inc
|
427.38 | 109.41B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
707.06 | 76.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
781.72 | 48.20B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
309.49 | 40.31B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
295.27 | 33.13B | 5.36B | 287.73M | 924.18M | 2.5229 |
Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-14 | Iniziato | Rodman & Renshaw | Buy |
| 2018-10-30 | Iniziato | Maxim Group | Buy |
| 2018-10-11 | Iniziato | Dawson James | Buy |
Adial Pharmaceuticals Inc Borsa (ADIL) Ultime notizie
Adial Pharmaceuticals files patent application for AD04 By Investing.com - Investing.com South Africa
Adial Pharmaceuticals files patent application for AD04 - Investing.com
Adial Pharmaceuticals Advances IP Portfolio with New U.S. Utility Patent Application, Positioning for Potential Market Exclusivity Through 2045 - The Manila Times
Exclusive: Adial Pharmaceuticals clears manufacturing milestone ahead of pivotal study for alcohol use disorder drug - MSN
Why did Adial Pharmaceuticals stock plunge over 20% after hours today? - MSN
Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight - GlobeNewswire Inc.
Adial Pharmaceuticals (ADIL) Submits Application to FDA's National Priority Voucher Program - GuruFocus
Adial Pharmaceuticals applies for FDA priority voucher program - Investing.com
Adial Pharmaceuticals Submits Application to FDA Commissioner’s National Priority Voucher (CNPV) Pilot Program for AD04 Clinical Development Program - The Manila Times
Adial Pharmaceuticals lead drug fits new policy mood as bipartisan bill signals broader lens on alcohol use disorder - MSN
Adial Pharmaceuticals (ADIL) price target decreased by 10.26% to 23.80 - MSN
ADIL Stock Price, Quote & Chart | ADIAL PHARMACEUTICALS INC (NASDAQ:ADIL) - ChartMill
EXCLUSIVE: Adial Pharmaceuticals Clears Manufacturing Milestone Ahead Of Pivotal Study For Alcohol Use Disorder Drug - Sahm
Adial Pharmaceuticals completes AD04 demonstration batch production By Investing.com - Investing.com Australia
ADIL (Adial Pharmaceuticals Inc) reports wider than expected Q4 2025 loss, yet stock notches 2.53 percent gain today.Quick Ratio - UBND thành phố Hải Phòng
Adial Pharmaceuticals (ADIL) Advances Production for Phase 3 Cli - GuruFocus
Adial Pharmaceuticals completes AD04 demonstration batch production - Investing.com
Adial Pharmaceuticals Completes Successful AD04 Demonstration Batch Production - Intellectia AI
Adial Pharmaceuticals Successfully Completes Manufacturing Of Demonstration Batch Production Enabling Clinical And Registration Production For AD04 Planned Phase 3 Trial - marketscreener.com
EXCLUSIVE: Adial Pharmaceuticals Clears Manufacturing Milestone Ahead Of Pivotal Study For Alcohol Use Di - Benzinga
Adial Pharma (ADIL) Stock: Technical Setup (Flirts with Breakout) 2026-04-18Professional Trade Ideas - Cổng thông tin điện tử tỉnh Tây Ninh
Adial Pharmaceuticals regains compliance with Nasdaq stockholders’ equity listing requirement - MSN
ADIL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Published on: 2026-04-10 14:04:42 - baoquankhu1.vn
Adial Pharmaceuticals Files 8-K on Executive Changes and Restricted Stock Award Agreement - Minichart
Adial Pharmaceuticals Implements New Executive Equity Compensation Plan - TipRanks
Adial Pharmaceuticals grants restricted stock awards to Cary Claiborne, Vinay Shah and Tony Goodman - TradingView
[Form 4] ADIAL PHARMACEUTICALS, INC. Insider Trading Activity - Stock Titan
Adial Pharmaceuticals (ADIL) director receives 9,185 stock options at $1.64 strike - Stock Titan
Adial (NASDAQ: ADIL) awards RSAs and stock options to board members - Stock Titan
Director at Adial (NASDAQ: ADIL) receives 9,185 restricted shares - Stock Titan
Adial Pharmaceuticals (ADIL) CFO receives 17,325-share restricted stock grant - Stock Titan
ADIAL (ADIL) director awarded 9,185 restricted shares in equity grant - Stock Titan
Adial Pharmaceuticals (NASDAQ: ADIL) CEO granted 37,985 shares - Stock Titan
Is Adial Pharma (ADIL) Stock Trending Down | Price at $1.79, Up 5.92%Community Volume Signals - Cổng thông tin điện tử tỉnh Lào Cai
Investor Mood: Will Adial Pharmaceuticals Inc benefit from government policy2026 Selloffs & AI Enhanced Trading Signals - baoquankhu1.vn
Is Adial Pharma (ADIL) Stock Overpriced Now | Price at $1.69, Down 2.31%Cycle Analysis - Cổng thông tin điện tử tỉnh Lào Cai
Hedge Fund Bets: Whats the MACD signal for Adial Pharmaceuticals Inc2026 Dividend Review & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Market Moves: Whats Adial Pharmaceuticals Incs historical returnDollar Strength & Daily Stock Trend Reports - baoquankhu1.vn
Aug Closing: Does Adial Pharmaceuticals Inc offer margin of safetyStock Surge & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Valuation Update: Will Adial Pharmaceuticals Inc benefit from geopolitical trends2026 Review & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Adial Pharmaceuticals Lead Drug Fits New Policy Mood As Bipartisan Bill Signals Broader Lens On Alcohol Use Disorder - Sahm
Adial Pharmaceuticals Commends Introduction of H.R. 7091 to Expand Access to Alcohol Use Disorder Treatments for Veterans - Quiver Quantitative
Adial Pharmaceuticals Commends Congress on Introduction of - GlobeNewswire
Smart Money: Does Adial Pharmaceuticals Inc have a competitive edge2026 Trade Ideas & Daily Stock Trend Reports - baoquankhu1.vn
Nasdaq Moves: Whats the beta of Adial Pharmaceuticals Inc stock2026 Analyst Calls & Real-Time Volume Analysis - baoquankhu1.vn
Adial Pharmaceuticals Inc Azioni (ADIL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):